Published in Obesity and Diabetes Week, November 6th, 2006
"Low plasma erythropoeitin (EPO) is a key causal factor in the anaemia of diabetic patients. The aim of this study was to investigate the prevalence of anaemia in relation to EPO in patients with type 2 diabetes," researchers in Kuwait report.
O.A. Mojiminiyi and colleagues at Kuwait University described, "In a clinic-based cross-sectional study of 161 type 2 diabetes patients, we measured EPO, ferritin and full...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.